Swiss Life Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.8K Buy
17,252
+1,356
+9% +$7.28K ﹤0.01% 1603
2026
Q1
$85.9K Buy
15,896
+4,189
+36% +$25.1K ﹤0.01% 1465
2025
Q4
$81.3K Buy
11,707
+599
+5% +$3.94K ﹤0.01% 1352
2025
Q3
$71.6K Buy
+11,108
New +$75.9K ﹤0.01% 1166
2019
Q2
Sell
-8,726
Closed -$215K 540
2019
Q1
$215K Buy
+8,726
New +$208K ﹤0.01% 494
2018
Q4
Sell
-10,504
Closed -$270K 222
2018
Q3
$270K Sell
10,504
-111
-1% -$2.54K ﹤0.01% 501
2018
Q2
$247K Buy
+10,615
New +$219K ﹤0.01% 496

Other funds holding BHC

Swiss Life Asset Management's BHC Position: Q2 2026 in Review

Swiss Life Asset Management increased its Bausch Health (BHC) stake by 8.5% in Q2 2026, buying an estimated $7.28K and bringing the position to 17,252 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Swiss Life Asset Management first reported a position in BHC in Q2 2018 and has held it in 7 quarters since. The position peaked at $270K in Q3 2018. 145 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Swiss Life Asset Management held 17,252 shares of Bausch Health worth $84.8K as of Q2 2026.
  • Swiss Life Asset Management bought 1,356 Bausch Health shares in Q2 2026, an estimated $7.28K.
  • Bausch Health made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1603 holding.
  • Swiss Life Asset Management first reported a position in Bausch Health in Q2 2018 and has held it in 7 quarters since.
  • Swiss Life Asset Management's Bausch Health position peaked at $270K in Q3 2018.
  • 145 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.